Precision-cut liver slices as a model for the evaluation of host-targeting agents against hepatitis B and delta viruses https://www.biorxiv.org/content/10.64898/2025.12.06.692712v1
Armando Andres Roca Suarez
@andresroca.bsky.social
Virologist seeking to understand the complexities of liver disease by day and of brazilian jiu-jitsu by night. @ihuhepatolyon.bsky.social #Liversky #Hepsky
⏳ Only 2 weeks left to submit abstracts for #HEP-DART 2025! Deadline: September 29, 2025 Join leading researchers and clinicians in 🌎 Honolulu, Hawaii, and share your latest work in #hepatitis research, treatment, and global health. 👉 informedhorizonseducation.com/abstracts-he...
Thank you team! You did an amazing work at presenting your data and we had a lot of fun!!! #HBV2025 @anrs-mie.bsky.social @ihuhepatolyon.bsky.social
Backstage from the #HBV2025 international meeting. we’re getting ready to welcome you all in Berlin! @anrs-mie.bsky.social @ihuhepatolyon.bsky.social
🎓 [OFFRE DE POST-DOC – 24 mois] 📍 Domaine : Santé publique / Épidémiologie 📅 Candidatures jusqu’au 17 octobre 2025 🎓 Profil recherché : - Doctorat en santé publique, épidémiologie ou discipline connexe - Solides compétences en analyse de données 👉 Plus d'informations dans la fiche de poste
FDA approves semaglutide for adults with metabolic-associated steatohepatitis with moderate-to-advanced fibrosis www.fda.gov/drugs/news-e... #LiverSky #MedSky
FDA Approves Treatment for Serious Liver Disease Known as ‘MASH’
Action Will Provide New Therapy for Growing Public Health Issue
fda.gov
We look forward to receiving your contributions to the special issue "Cellular Immune Response to Hepatitis Viruses". Deadline : 31 January 2026 #Hepsky #Liversky #Medsky www.mdpi.com/journal/viru...
mdpi.com
🌍 Today is #WorldHepatitisDay 2025! 〽️ At IHU Everest, we are committed to raising #awareness and support the global campaign: “Let’s break it down.” www.worldhepatitisday.org/take-action/ 🤝 Let’s unite around one powerful message: Take action. Get tested. End the stigma. #EndStigma #HealthForAll
www.thelancet.com/journals/lan... #HBV #Medsky #Hepsky #Liversky
Scientific and medical evidence informing expansion of hepatitis B treatment guidelines
Chronic hepatitis B treatment relies on nucleoside or nucleotide analogue drugs that suppress hepatitis B virus (HBV) replication, normalise liver enzymes, and slow disease progression with excellent ...
thelancet.com
👟🎽🚲 16-22 juin : bougez pour le don d’organes ! 🫵 Rejoignez la course virtuelle STRAVA : marchez, courez ou pédalez. 🎯 Défi collectif : atteindre 6034 km, nombre de greffes réalisées en France en 2024. 📲 Infos via le QR code, rejoignez-nous vite ! #DéfiDon #DonDorganes #TeamHCL #Greffe #Solidarité🤝!
🚨 Register now for the 2025 International HBV Meeting! 📅Sept. 8-12, 2025 📍Berlin, Germany ➡️ Deadline for abstract submission June 16th. Early bird registration before July, 18th 🔗 Visit www.hbvmeeting.org for details @ihuhepatolyon.bsky.social @anrs-mie.bsky.social @easlnews.bsky.social
Researchers with ADHD discuss its peaks and valleys and how they structure their work lives to succeed https://go.nature.com/3FitQh4
Scientists with ADHD speak up: when fire meets focus
Nature - Researchers with ADHD discuss its peaks and valleys and how they structure their work lives to succeed.
go.nature.com
📢 We are delighted to announce that Prof. John Tavis 🇺🇲 will be giving an in-person talk in Lyon 🇫🇷 🗓️ Tuesday, May 13, 2025 🕤 9:30 – 10:30 AM His invited talk, "HBV polymerase: Biochemical engineering and drug discovery", is an open event. We look forward to welcoming you! #HBV #hepatology #liver
The new EASL CPGs on HBV infection have been released yesterday at #EASLCongress What an effort, but what a great journey with an outstanding panel of colleagues! #HBV #Hepatology @ihuhepatolyon.bsky.social doi.org/10.1016/j.jh...
🆕 🔬 🧪 Open call for a Junior Professor Position to develop an ambitious project in #liver #pathobiology on #bioinformatics & #biostatistics that will cover one or more of these topics: #virology, metabolism, #oncology, #immunology etc. 📆 Deadline: 1st June 2025 www.ihu-hepatolyon.fr/en/join-us/
🥁 A second call for application is open for MSCA-COFUND International Doctoral Programme ArchiFun. We have a project linking HBV splicing and liver pathogenesis. The deadline for application is May 31st 2025. ⬇️ More details here: lnkd.in/d459VH_B #HBV #liver #PhD @ihuhepatolyon.bsky.social
This link will take you to a page that’s not on LinkedIn
lnkd.in
🔙 [ Looking back] on our annual #Hepatology and #Liver Transplantation Days! 📣 We were glad to welcome Catherine Postic as one of our guest speakers. During her impactful presentation, titled 👉 “Novel insights into glucose and MASLD”, she shared her most recent research. #MASLD #GlucoseMetabolism
💡📅 As World Liver Day approaches on April 19, 2025, our teams are proud to stand alongside the 🌍 global community in raising awareness. 👉 Learn more about our initiatives to preserve, heal, and save livers on our website: www.ihu-hepatolyon.fr/en #WorldLiverDay #MedicalResearch #HealthAwareness
🔝〽️2-day multidisciplinary event on #hepatology and #liver #transplantation! On April 8–9 2025 in Lyon, we had the pleasure of bringing together our community and a diverse audience to share the latest advances in basic, translational, and #clinical #research in hepatology within our IHU.
🔙 on our Hepatology and Liver Transplantation Days! 🤝 We had the pleasure of welcoming @tz-hirsch.bsky.social for a presentation titled: Evolution of Hepatoblastoma: From #Liver Development to Chemoresistance. 🧫 His talk sparked dynamic discussions during the session on #hepatic #pathogenesis.
Great adventure for our #PaThLiv unit members at #GHS2025! Three oral presentations, a poster and always a strong engagement for open science and against viral hepatitis! @ihuhepatolyon.bsky.social #Liversky #HBV #standup4science
What’s your job? Is it hard? How do you become a researcher? What skills do you need to begin? Is the salary adequate? 😅 talking with high school students and presenting research and @ihuhepatolyon.bsky.social #womeninSTEM #standup4science
Présentation sur les nouvelles approches pour guérir l’Hépatite B par Fabien Zoulim de @ihuhepatolyon.bsky.social
New dimension in viral hepatitis research egastroenterology.bmj.com/content/2/3/... @testoniresearch.bsky.social #liversky #hepsky #medsky
New dimension in viral hepatitis research
Chronic hepatitis B is the leading cause of hepatocellular carcinoma and a significant global health issue, affecting over 296 million people worldwide, with 15 million people coinfected with hepatiti...
egastroenterology.bmj.com
Here we are! The lab family grows: come and join us! we are looking for - 1 post-doc - 2 research engineers - 1 cell culture technician More info here: www.ihu-hepatolyon.fr/en/join-us/ @ihuhepatolyon.bsky.social @inserm.fr @anrs-mie.bsky.social #HBV #hepatology #3Dmodels #virology #antivirals
🥁 WE'RE HIRING! We are looking for: ✅ 1 Post-Doc fellow ✅ 2 research engineers ✅ 1 research technician motivated to work on HBV/HDV biology and antiviral treatments and on the development of innovative 3D ex-vivo cell culture models! www.ihu-hepatolyon.fr/en/join-us/ #HBV #research #virology
🆕 Les 25 et 26 mars 2025 l'IHU co-organise le Séminaire ACHBPT à l’Hôpital de la Croix-Rousse à Lyon. Plus d'information sur notre site web. www.ihu-hepatolyon.fr/strategie-na... L'inscription est obligatoire avant le 1er mars 2025. #HCL #IHU #hepatology #liver #surgery #transplantation
Stratégie Nationale Bipartition Hépatique SPLIT - IHL - Institut d’Hépatologie de Lyon
25 – 26 mars 2025 à Lyon Séminaire ACHBPT à l’Hôpital de la Croix-Rousse à Lyon – Salle Vaïsse Organisation : ACHBPT Institut d’Hépatologie de Lyon, IHU EVEREST Association à but scientifique pour l’a...
ihu-hepatolyon.fr
📣 Happy to share some pictures from our last event on Hepatic organoids and and ex-vivo models, held on Monday 3rd February organized by Jennifer Rieusset at CarMeN Laboratory INRAE UMR1397-INSERM U1060. Thanks again to all the speakers and attendees. #organoids #Medsky #Hepsky #Liversky